Tumor Endothelial Cells

被引:323
作者
Dudley, Andrew C. [1 ,2 ,3 ]
机构
[1] Univ N Carolina, Dept Cellular & Mol Physiol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[3] McAllister Heart Inst, Chapel Hill, NC 27599 USA
基金
美国国家卫生研究院;
关键词
VASCULAR GENE-EXPRESSION; HEMATOPOIETIC STEM-CELLS; MARROW-DERIVED CELLS; BONE-MARROW; BLOOD-VESSELS; GROWTH-FACTOR; MOUSE MODEL; MOLECULAR CHARACTERIZATION; EXTRACELLULAR-MATRIX; PROGENITOR CELLS;
D O I
10.1101/cshperspect.a006536
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
The vascular endothelium is a dynamic cellular "organ" that controls passage of nutrients into tissues, maintains the flow of blood, and regulates the trafficking of leukocytes. In tumors, factors such as hypoxia and chronic growth factor stimulation result in endothelial dysfunction. For example, tumor blood vessels have irregular diameters; they are fragile, leaky, and blood flow is abnormal. There is now good evidence that these abnormalities in the tumor endothelium contribute to tumor growth and metastasis. Thus, determining the biological basis underlying these abnormalities is critical for understanding the pathophysiology of tumor progression and facilitating the design and delivery of effective antiangiogenic therapies.
引用
收藏
页数:18
相关论文
共 157 条
[1]
Contribution of bone marrow-derived cells to blood vessels in ischemic tissues and tumors [J].
Aghi, M ;
Chiocca, EA .
MOLECULAR THERAPY, 2005, 12 (06) :994-1005
[2]
Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: Role of bone marrow-derived myelomonocytic cells [J].
Ahn, G-One ;
Brown, J. Martin .
CANCER CELL, 2008, 13 (03) :193-205
[3]
Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment [J].
Ahn, G-One ;
Tseng, Diane ;
Liao, Cho-Hwa ;
Dorie, Mary Jo ;
Czechowicz, Agnieszka ;
Brown, J. Martin .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (18) :8363-8368
[4]
Mechanisms of endothelial cell heterogeneity in health and disease [J].
Aird, WC .
CIRCULATION RESEARCH, 2006, 98 (02) :159-162
[5]
Molecular heterogeneity of tumor endothelium [J].
Aird, William C. .
CELL AND TISSUE RESEARCH, 2009, 335 (01) :271-281
[6]
Phenotypic and functional characteristics of tumour-derived microvascular endothelial cells [J].
Alessandri, G ;
Chirivi, RGS ;
Fiorentini, S ;
Dossi, R ;
Bonardelli, S ;
Giulini, SM ;
Zanetta, G ;
Landoni, F ;
Graziotti, PP ;
Turano, A ;
Caruso, A ;
Zardi, L ;
Giavazzi, R ;
Bani, MR .
CLINICAL & EXPERIMENTAL METASTASIS, 1999, 17 (08) :655-662
[7]
Murine lewis lung carcinoma-derived endothelium expresses markers of endothelial activation and requires tumor-specific extracellular matrix in vitro [J].
Allport, JR ;
Weissleder, R .
NEOPLASIA, 2003, 5 (03) :205-217
[8]
Targeting EGFR activity in blood vessels is sufficient to inhibit tumor growth and is accompanied by an increase in VEGFR-2 dependence in tumor endothelial cells [J].
Amin, Dhara N. ;
Bielenberg, Diane R. ;
Lifshits, Eugene ;
Heymach, John V. ;
Klagsbrun, Michael .
MICROVASCULAR RESEARCH, 2008, 76 (01) :15-22
[9]
Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors [J].
Amin, DN ;
Hida, K ;
Bielenberg, DR ;
Klagsbrun, M .
CANCER RESEARCH, 2006, 66 (04) :2173-2180
[10]
MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis [J].
Anand, Sudarshan ;
Majeti, Bharat K. ;
Acevedo, Lisette M. ;
Murphy, Eric A. ;
Mukthavaram, Rajesh ;
Scheppke, Lea ;
Huang, Miller ;
Shields, David J. ;
Lindquist, Jeffrey N. ;
Lapinski, Philip E. ;
King, Philip D. ;
Weis, Sara M. ;
Cheresh, David A. .
NATURE MEDICINE, 2010, 16 (08) :909-U109